Given Prr has 30m in the bank and their technology,s and treatment success not quite there.They might have a lash at cap at least there is an emerging business
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game